Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 8:03 PM
Ignite Modification Date:
2025-12-24 @ 8:03 PM
NCT ID:
NCT03581604
Eligibility Criteria:
Inclusion Criteria:
* Adult patients who are referred to the department of Pulmonary medicine with clinical history suspected of having penicillin allergy.
* The control group will be healthy adult volunteers with no history of any personal or family history of drug allergy, atopy, inflammatory or autoimmune diseases.
Exclusion Criteria:
* Systemic reactions such as DRESS, any internal organ involvement
* Clinical history of Type II-III hypersensitivity reaction
* Severe Type IV hypersensitivity reaction such as Stevens-Johnson syndrome, toxic epidermal necrolysis, DRESS, vasculitis, acute generalized exanthematous pustulosis
* Chronic idiopathic urticaria on antihistamine maintenance treatment/anti-IgE treatment
* Medication which can affect the test outcome
* Active signs of an underlying disease such as uncontrolled asthma
* Cardiac disease with increased risk of serious anaphylaxis
* Pregnancy/Breastfeeding
* Reaction within the last 4-6 weeks
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
85 Years
Study:
NCT03581604
Study Brief:
Protocol Section:
NCT03581604